Effect of indomethacin on cerebral blood flow velocities in very low birth weight neonates with a patent ductus arteriosus

Dev Pharmacol Ther. 1993;20(1-2):100-6. doi: 10.1159/000457546.

Abstract

The effect of repeated doses of indomethacin on mean peak velocity (MPV) and time-averaged mean velocity in the middle cerebral artery was assessed in 10 ventilated neonates with a patent ductus arteriosus using colour/duplex Doppler technique prior to, and 10, 30, and 120 min after the first and the third dose. Velocities were significantly reduced up to 120 min after the first dose. The third dose resulted in a significant reduction in MPV at 10 and 30 min following treatment. This reduction was half of that observed after the first dose. Systemic blood pressure (BP) and heart rate did not change significantly after each separate dose. However, by the third dose, mean and diastolic BP were significantly increased from pretreatment levels. The attenuated response of cerebral blood flow (CBF) velocities to the third dose of indomethacin compared with the first dose is probably related to altered haemodynamics. Indomethacin should be used cautiously in infants with other conditions which are known to decrease CBF such as hypotension, hypocarbia and polycythaemia.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Flow Velocity / drug effects
  • Cerebrovascular Circulation / drug effects*
  • Ductus Arteriosus, Patent / diagnostic imaging
  • Ductus Arteriosus, Patent / drug therapy*
  • Ductus Arteriosus, Patent / physiopathology
  • Humans
  • Indomethacin / pharmacology*
  • Infant, Low Birth Weight / physiology*
  • Infant, Newborn
  • Prospective Studies
  • Respiration, Artificial
  • Ultrasonography, Doppler, Color
  • Ultrasonography, Doppler, Duplex

Substances

  • Indomethacin